John Gallagher Sells 431 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) COO John Gallagher sold 431 shares of the stock in a transaction that occurred on Tuesday, July 28th. The shares were sold at an average price of $25.08, for a total transaction of $10,809.48. Following the transaction, the chief operating officer owned 32,203 shares in the company, valued at $807,651.24. The trade was a 1.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trupanion Trading Up 0.0%

Shares of TRUP opened at $24.49 on Friday. The firm has a market cap of $1.07 billion, a price-to-earnings ratio of 41.51 and a beta of 1.39. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.73 and a current ratio of 1.73. Trupanion, Inc. has a fifty-two week low of $21.16 and a fifty-two week high of $57.00. The firm has a 50 day moving average price of $24.33 and a 200-day moving average price of $26.48.

Trupanion (NASDAQ:TRUPGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. The company had revenue of $384.05 million during the quarter, compared to analysts’ expectations of $379.77 million. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The firm’s revenue was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.03) EPS. As a group, equities research analysts forecast that Trupanion, Inc. will post 0.55 earnings per share for the current year.

Institutional Investors Weigh In On Trupanion

A number of large investors have recently modified their holdings of TRUP. Parallel Advisors LLC raised its stake in Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after buying an additional 1,722 shares in the last quarter. Kemnay Advisory Services Inc. purchased a new stake in Trupanion in the fourth quarter worth about $64,000. Kelleher Financial Advisors purchased a new stake in Trupanion in the third quarter worth about $74,000. Advisory Services Network LLC bought a new stake in Trupanion during the 3rd quarter valued at approximately $160,000. Finally, Fifth Third Bancorp boosted its position in Trupanion by 2,911.1% during the 1st quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock valued at $194,000 after acquiring an additional 7,336 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 24th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. Stifel Nicolaus set a $28.00 target price on Trupanion in a research note on Friday, June 26th. Atlantic Securities set a $42.00 target price on Trupanion in a report on Wednesday, July 15th. Finally, Bank of America reduced their price target on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $41.60.

View Our Latest Report on TRUP

About Trupanion

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Featured Articles

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.